<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The costs of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> care, length of hospital stay (LOS), and outcome in patients with cardioembolic <z:hpo ids='HP_0001297'>stroke</z:hpo> or cardioembolic <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> (<z:hpo ids='HP_0002326'>TIA</z:hpo>) were investigated with the aim of estimating the clinical and health-economic impacts of cerebral cardioembolism </plain></SENT>
<SENT sid="1" pm="."><plain>The study population consisted of 511 consecutive patients with the diagnosis of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> (n = 379) or <z:hpo ids='HP_0002326'>TIA</z:hpo> (n = 132) treated at the Department of Neurology, Philipps University, Marburg </plain></SENT>
<SENT sid="2" pm="."><plain>Cerebral cardioembolism was defined according to the criteria of the <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">Cerebral Embolism</z:e> Task Force </plain></SENT>
<SENT sid="3" pm="."><plain>Clinical status was assessed by means of Barthel index (BI) and modified Rankin Scale </plain></SENT>
<SENT sid="4" pm="."><plain>Costs were calculated using a bottom-up approach </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> costs (in Euros) were inflated to the 2008 level </plain></SENT>
<SENT sid="6" pm="."><plain>Compared to non-cardioembolic <z:hpo ids='HP_0001297'>stroke</z:hpo> (n = 278) patients, patients who had suffered cardioembolic <z:hpo ids='HP_0001297'>stroke</z:hpo> (n = 101) had more severe clinical deficits on admission (BI 46.3 +/- 27.0 vs. 59.3 +/- 34.1; P &lt; 0.01), worse recovery (BI on discharge 59.2 +/- 28.9 vs. 73.1 +/- 33.4; P &lt; 0.01), and increased LOS (12.6 +/- 5.7 vs. 10.0 +/- 7.8 days; P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>The latter also required a relatively higher daily resource utilization due to increased expenses for personnel and diagnostics </plain></SENT>
<SENT sid="8" pm="."><plain>Mean costs of <z:hpo ids='HP_0011009'>acute</z:hpo> care for patients with cardioembolic <z:hpo ids='HP_0001297'>stroke</z:hpo> [euro 4890 per patient (95% confidence interval 4460-5200)] were significantly higher than those for patients with non-cardioembolic <z:hpo ids='HP_0001297'>stroke</z:hpo> [euro 3550 (95% confidence interval 3250-3850); P &lt; 0.01] </plain></SENT>
<SENT sid="9" pm="."><plain>The clinical and health-economic impact of cardiogenic <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> on <z:hpo ids='HP_0001297'>stroke</z:hpo> care is considerable </plain></SENT>
<SENT sid="10" pm="."><plain>Patients with cardioembolic <z:hpo ids='HP_0001297'>stroke</z:hpo>/<z:hpo ids='HP_0002326'>TIA</z:hpo> are more severely impaired, and they require longer hospital treatment and increased resource utilization </plain></SENT>
<SENT sid="11" pm="."><plain>Costs of <z:hpo ids='HP_0011009'>acute</z:hpo> care of cardioembolic <z:hpo ids='HP_0001297'>stroke</z:hpo>/<z:hpo ids='HP_0002326'>TIA</z:hpo> patients may exceed those of non-cardioembolic <z:hpo ids='HP_0001297'>stroke</z:hpo>/<z:hpo ids='HP_0002326'>TIA</z:hpo> by up to 40% </plain></SENT>
</text></document>